NCT03380754

Brief Summary

The aim of this study is to investigate the effect of preoperative carbohydrate rich drinks on postoperative nausea and vomiting in total knee arthroplasty. This is a prospective, double blinded, randomized controlled trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 31, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 21, 2017

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
Last Updated

February 17, 2020

Status Verified

February 1, 2020

Enrollment Period

2 years

First QC Date

October 31, 2017

Last Update Submit

February 13, 2020

Conditions

Keywords

NauseaVomitingKnee ArthroplastyPONVTKA

Outcome Measures

Primary Outcomes (6)

  • Post operative nausea

    Nausea, assess by questionnaire, 10 point scale (0 = no nausea, 10 = very nauseous, and medical record.

    4 hours postoperatively

  • Post operative nausea

    Nausea, assess by questionnaire, 10 point scale (0 = no nausea, 10 = very nauseous, and medical record.

    12 hours postoperatively

  • Post operative nausea

    Nausea, assess by questionnaire, 10 point scale (0 = no nausea, 10 = very nauseous, and medical record.

    24 hours postoperatively

  • Post operative vomiting

    Vomiting, assess by questionnaire, 10 point scale (0 = no vomiting, 10 = copious emesis, and medical record notes of emesis.

    4 hours postoperatively

  • Post operative vomiting

    Vomiting, assess by questionnaire, 10 point scale (0 = no vomiting, 10 = copious emesis, and medical record notes of emesis.

    12 hours postoperatively

  • Post operative vomiting

    Vomiting, assess by questionnaire, 10 point scale (0 = no vomiting, 10 = copious emesis, and medical record notes of emesis.

    24 hours postoperatively

Secondary Outcomes (5)

  • Length of hospital stay

    From the time of hospital admission following surgery, until the time of hospital discharge as recorded in EMR, assessed up to 1 month

  • Post operative opiate consumption

    From the time of surgery until the time of hospital discharge, assessed up to 72 hours postoperatively

  • Post operative pain scores

    From the time of surgery until the time of hospital discharge, assessed up to 72 hours postoperatively

  • Peri operative hunger and discomfort

    4 hours, 12 hours, and 24 hours postoperatively

  • Incidence of secondary adverse events

    From the time of surgery until the time of hospital discharge, assessed up to 1 month postoperatively

Study Arms (3)

Carbohydrate Rich Drink

EXPERIMENTAL

Group A will receive the carbohydrate rich drink, Nutricia preOp. This is the intervention group.

Dietary Supplement: Nutricia preOp

Placebo Drink

PLACEBO COMPARATOR

Group B will receive placebo, Nestle Splash Lemon Flavor Water (Placebo) (similarly flavored and appearing water, however with no calorie, carbohydrate or nutritional content).

Other: Nestle Splash Lemon Flavor Water (Placebo)

No Drink

NO INTERVENTION

Group C will not receive any drink. This group will follow normal protocol.

Interventions

Nutricia preOpDIETARY_SUPPLEMENT

A clear, non-carbonated lemon-flavored, iso-osmolar carbohydrate drink for preoperative surgical patients. Used in studies supporting the Enhanced Recovery After Surgery (ERAS) Society Consensus Guidelines.

Also known as: Carbohydrate rich drink
Carbohydrate Rich Drink

Placebo control drink. PURIFIED WATER, NATURAL FLAVORS, CITRIC ACID, SODIUM POLYPHOSPHATE, POTASSIUM SORBATE (PRESERVE FRESHNESS), POTASSIUM BENZOATE (PRESERVE FRESHNESS), SUCRALOSE, ACESULFAME POTASSIUM, CALCIUM DISODIUM EDTA, MAGNESIUM SULFATE.

Placebo Drink

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (\>18 years of age) scheduled for elective, unilateral, primary total knee arthroplasty
  • Able to give valid consent

You may not qualify if:

  • Impaired gastrointestinal motility
  • On pro-motility medication
  • Pregnancy
  • HbA1c \> 7.5
  • Fasting glucose \>200
  • Acquired immunodeficiency
  • Renal failure (creatinine \> 2 mg/dL)
  • Cirrhosis
  • Severe malnutrition.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henry Ford Hospital

Detroit, Michigan, 48202, United States

Location

Related Publications (1)

  • Kadado A, Shaw JH, Ayoola AS, Akioyamen NO, North WT, Charters MA. Effects of Preoperative Carbohydrate-rich Drinks on Immediate Postoperative Outcomes in Total Knee Arthroplasty: A Randomized Controlled Trial. J Am Acad Orthop Surg. 2022 Jun 1;30(11):e833-e841. doi: 10.5435/JAAOS-D-21-00960. Epub 2022 Mar 18.

MeSH Terms

Conditions

VomitingNauseaPostoperative Nausea and Vomiting

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic Processes

Study Officials

  • Michael Charters, MD

    Henry Ford Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Research assistant who is not involved in any of the patients clinical care is responsible for randomization collection of data. All others are blinded to the groups involved.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Prospective, randomized, double blinded, placebo controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, MD, Adult Joint Reconstruction

Study Record Dates

First Submitted

October 31, 2017

First Posted

December 21, 2017

Study Start

July 15, 2017

Primary Completion

August 1, 2019

Study Completion

August 1, 2019

Last Updated

February 17, 2020

Record last verified: 2020-02

Locations